ARCHIVES

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

Study Finds High-Risk Women Reluctant To Take Tamoxifen

December 25, 2009

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 14, 2000

In Brief: NCAB Approves Concept Of Converting Baltimore Program To Cancer Center; New DCCP Labs Named

June 5, 1981

$2.5 Million NCI Grant To Fund Brachytherapy Improvement

February 27, 2004

ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation

February 19, 2010

Roswell Park Hired 31 Faculty In 2002 In Second Wave of Recruitment

November 22, 2002